Nick Hart

With over 30 years of experience in the life sciences sector, Nick is a seasoned financial and operational executive. He has an impressive track record of significantly increasing company valuations, enabling next levels of growth and successful exits through sale or IPO.

Most recently, Nick was CFO at KBP Biosciences, a U.S. headquartered biotechnology company. Prior to this, he was CFO at Temptime Corporation, a private equity owned manufacturer of temperature monitors sold to Zebra Technologies. Nick played a key role in the successful sale and then its integration into Zebra.

Before Temptime, Nick was recruited as CFO of HemCon Medical Technologies following HemCon’s acquisition of Alltracel Pharmaceuticals Plc where Nick was CFO and Board member. Prior to joining Alltracel, he was CFO of Smart Holograms Ltd., Bioscience Managers Ltd. as well as Acting CEO, COO, and CFO of Cantab Pharmaceuticals Plc where he led the sale to Xenova Group Plc another publicly listed company.

Nick is a fellow member of the Chartered Institute of Management Accountants (FCMA) and has a degree in economics and statistics (BA) from Kingston University, London.